Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma hopes to expand drug success to other areas

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Gianmaria Feleppa and Stefano Casselli Discuss Building USA-EU Bridges on New to the Street | Gianmaria Feleppa , CEO , UCapital24 SpA.
00:10:00
ACG CEO Artem Volynets on $1bn Brazilian Mine Deal and Rebrand | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
Mod Resources: Dominating Botswana's Copper Belt with Expansive Exploration Opportunities
00:00:00
Update from Genesis HealthCare System CEO & President Matthew J. Perry
00:10:00
Ho Kuen Loon, Group CEO, and Ng Chong Jin, Group General Counsel of Fullerton Health, discuss their award-winning project and outline future plans for the company.
00:10:00
Shahar Bar, SVP of Video Products & Corporate Development at Harmonic Inc., discusses competition in the media industry.
00:10:00
Highcroft Mining's Unprecedented Silver Discovery and Expansion Plans for 2024
00:10:00
State Street Leads Clean Economy Transition: CEO Ron O'Hanley Shares Firm's ESG Priorities| Ron O’Hanley,CEO, State Street
00:10:00
Investing for the Long Run is the main focus|Brooks G. Gordon, Managing Director, W. P. Carey & Co. LLC
00:10:00
Wall Street Connected: Callon Petroleum | Joseph C Gatto Jr, CEO, Callon Petroleum CoCPE:NYQ
00:10:00
"Building Equity: Priscilla Almodovar's Leadership in US Housing Reform"
00:10:00
Market Insights with Derek Kelly and James Igoe | Derek Kelly, CEO, Hilltop Financial Planning.

© 2026 Nehu